Skip to Main Content

Paper Details

Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review.
Am J Ophthalmol Case Rep
0
2022
AIA, Anti-infliximab antibodies, NIU, Serum infliximab, anti-infliximab antibodies, infliximab, noninfectious uveitis, ocular inflammation, patients, scleritis
Author NameAffiliation
Samuel HanMassachusetts Eye and Ear Infirmary, Harvard Medical School
Lucia SobrinMassachusetts Eye and Ear Infirmary, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2